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Abstract
The presence of inflammatory cells and MPO (myeloperoxidase) in the arterial wall after vascular injury could
increase neointima formation by modification of phospholipids. The present study investigates how these
phospholipids, in particular oxidized and chlorinated species, are altered within injured vessels and how they affect
VSMC (vascular smooth muscle cell) remodelling processes. Vascular injury was induced in C57BL/6 mice and high
fat-fed ApoE−/− (apolipoprotein E) mice by wire denudation and ligation of the left carotid artery (LCA). Neointimal
and medial composition was assessed using immunohistochemistry and ESI–MS. Primary rabbit aortic SMCs
(smooth muscle cells) were utilized to examine the effects of modified lipids on VSMC proliferation, viability and
migration at a cellular level. Neointimal area, measured as intima-to-media ratio, was significantly larger in
wire-injured ApoE−/− mice (3.62 +− 0.49 compared with 0.83 +− 0.25 in C57BL/6 mice, n= 3) and there was
increased oxidized low-density lipoprotein (oxLDL) infiltration and elevated plasma MPO levels. Relative increases in
lysophosphatidylcholines and unsaturated phosphatidylcholines (PCs) were also observed in wire-injured ApoE−/−
carotid arteries. Chlorinated lipids had no effect on VSMC proliferation, viability or migration whereas chronic
incubation with oxidized phospholipids stimulated proliferation in the presence of fetal calf serum [154.8 +− 14.2%
of viable cells at 1 μM PGPC (1-palmitoyl-2-glutaroyl-sn-glycero-3-phosphocholine) compared with control, n= 6]. In
conclusion, ApoE−/− mice with an inflammatory phenotype develop more neointima in wire-injured arteries and
accumulation of oxidized lipids in the vessel wall may propagate this effect.
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INTRODUCTION
Revascularization procedures such as balloon angioplasty and
stenting often result in neointimal hyperplasia in patients. This
can be considered an exaggerated form of wound healing char-
acterized by luminal (re)narrowing due to smooth muscle hyper-
plasia and rapid vascular remodelling of the instrumented vessel
[1]. The formation of neointima is a complex and multifactorial
process, but excessive VSMC (vascular smooth muscle cell) pro-
liferation andmigration, inflammation and the production of large
amounts of ECM (extracellular matrix) are all involved [2].
Inflammation appears to be pivotal in driving neointima form-
ation. In a rabbit model of balloon injury, there is early up-
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regulation of leucocyte adhesion molecules on the injured vessel
with increased inflammatory cell adhesion and transmigration
[3]. There is also evidence of sustained inflammation, with in-
flammatory cells remaining in close proximity to the stent struts
up to 28 days after placement [4]. In themousewire injurymodel,
increased leucocyte adhesion to injured vessels is observed
ex vivo up to 28 days following surgery [5]. The importance of
circulating inflammatory cells was demonstrated in neutropenic
rabbits, which had a significantly reduced extent of neointima
at 28 days [6]. ApoE−/− mice (deficient in apolipoprotein E)
are hyperlipidaemic and demonstrate greater neointima forma-
tion following vascular injury induced by either wire denudation
[7] or ex vivo aortic stenting and interpositional grafting [8].
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ApoE−/− mice also show increased inflammatory cell adhesion
to the injured carotid artery intima and, intriguingly, total plasma
cholesterol correlated with neointima formation [7]. However,
what remains to be determined is the role that modified lipids
present in the vessel wall play in mediating the enhanced neoin-
tima formation in hyperlipidaemic mice.
Modification of LDL (low-density lipoprotein) and formation
of oxidized phospholipids contributes to the pathophysiology of
atherosclerosis [9]. The phagocytic enzyme MPO (myeloperoxi-
dase) catalyses the production of HOCl from H2O2 and chloride
anions [10] and can cause chlorination of phospholipids [11]. The
active forms of MPO as well as HOCl-modified LDL are present
in human atherosclerotic plaques [12,13] and correlate with an
increase in the intima-to-media ratio in human iliac arteries [14].
Phospholipid chlorohydrins have a multitude of biological effects
[15,16]. Their high polarity can disrupt cell membranes and cause
toxicity in myeloid and endothelial cells [17,18] and can also in-
duce leucocyte adhesion by up-regulation of adhesion molecules
[19]. Lysophosphatidylcholine–chlorohydrins have been detec-
ted in human atherosclerotic vessels with a 60-fold increase in
plaques compared with healthy tissue [20] and fatty acid chloro-
hydrins have been found at high levels in the plasma of patients
with acute pancreatitis [21]. Other chlorinated species such as
2-ClHDA (2-chlorohexadecanal) are produced by the action of
MPO on plasmalogens [22] and have also been detected in human
atherosclerotic plaques [23].
Oxidized phospholipids, such as oxidized PAPC (1-
palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine) and its
constituents, POVPC (1-palmitoyl-2-oxovaleroyl-sn-glycero-3-
phosphocholine) and PGPC (1-palmitoyl-2-glutaroyl-sn-glycero-
3-phosphocholine), increase expression of pro-inflammatory
genes in endothelial cells [24] and participate in the phenotypic
switching ofVSMCs that occurs following injury [25]. PAPC also
induces monocyte adhesion and inflammation in atherosclerotic
mice in vivo [26]. Several studies, including some conducted
in vivo, have demonstrated that oxidized phospholipids can influ-
encemany of the processes involved in vascular remodelling such
as VSMC proliferation, migration and ECM production [27–30].
In the present study, we used amousemodel of vascular injury
in normal and hyperlipidaemic ApoE−/− mice to generate vessels
containing neointima. By comparing the lipid profile in the in-
jured and contralateral uninjured carotid arteries, we were able to
study how the presence of modified phospholipids changes in an
injured artery with neointima and how plasma hyperlipidaemia
influences this. We then studied the effects of some oxidized and
chlorinated lipids known to be present in oxLDL (oxidized LDL)
on cultured VSMCs to assess whether the change in lipid pro-
file observed in injured arteries could drive the main processes
involved in neointima formation.
MATERIALS AND METHODS
Animals
All experiments were performed in accordance with the United
Kingdom Animals (Scientific Procedure) Act of 1986. Weight-
matchedC57BL/6 andApoE−/− mice (22–29 g)were 8–10 weeks
of age at the start of the surgical procedure.Miceweremaintained
on 12-h cycles of light and dark and at ambient temperature.
C57BL/6 mice were fed a standard chow diet whereas ApoE−/−
mice commenced a high fat diet (21% lard and 0.15% choles-
terol, SDS) at 6 weeks of age and continued on this throughout
the study period.
Murine carotid artery injury model
Mice were given pre-operative analgaesia [i.p. (intraperi-
toneal) buprenorphine; 0.1 mg/kg], antiplatelet therapy (i.p.
dipyridamole; 2.5 mg) and saline (0.5 ml subcutaneously). Ca-
rotid injury was performed according to an adapted method
previously described [5]. General anaesthesia was induced by in-
halation of 3% isoflurane supplemented with oxygen and main-
tained at 1.5% isoflurane throughout the procedure. The LCA
(left carotid artery) was exposed and the proximal end ligated.
An incision was made and a nylon fishing line [external diameter
0.014 inches (1 inch= 0.0254 m)] with a blunt, spherical tip was
inserted and advanced down the vessel with a torquing motion to
ensure endothelial damage. The artery was then ligated distal
to the incision site. Mice where the artery was ligated without the
insertion of the nylon line were also investigated as ligation alone
has been shown to result in the formation of neointima [31]. After
14 days, micewere killed and carotid arteries harvested and either
fixed and embedded in paraffin wax for histological examination
or snap frozen for ESI–MS analysis.
Histological analysis
Paraffin embedded LCA andRCA (right carotid artery) were seri-
ally sectioned at 4 μm and stained with haematoxylin and eosin
to visualize and quantify medial and neointimal areas. To invest-
igate the presence of proliferating and apoptotic cells as well as
identify VSMCs in the vessel wall, immunohistochemistry was
utilized. Briefly, sections were rehydrated and antigens retrieved
by microwave pressure cooking in citric acid. Endogenous per-
oxidase and non-specific binding was blocked prior to primary
antibody incubation overnight at 4 ◦C. The primary antibodies
were diluted in 1% (w/v) BSA in PBS and used at the following
dilutions: αSMA (α smooth muscle actin), 1:200, active cas-
pase 3, 1:50, Ki67, 1:100 and E06, 1:100. Secondary antibody
(anti-rabbit IgG antibody; Vector Laboratories) or, in the case of
E06, anti-mouse IgG (Abcam) was added for 1 h at room tem-
perature before DAB chromagen solution (3,3-diaminobenzidine
and hydrogen peroxidase solution; Vector Laboratories) was
added for between 2 and 5 min to develop. Slides were then
counterstained with haematoxylin, dehydrated and coverslipped.
In all cases, a negative control where the primary antibody
was omitted was run concurrently. Staining was visualized us-
ing a light microscope and analysed using QCapture Pro 6.0
software.
Measurement of plasma MPO
The MPO content of plasma from C57BL/6 and ApoE−/− mice
was analysed using a mouse MPO ELISA kit (Hycult Biotech
Inc.). Plasma sampleswere diluted one in 16 in dilution buffer and
the assay was performed as per the manufacturer’s instructions.
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A standard curve ranging from 1.6 to 100 ng/ml was included
for each experiment. Absorbance values were measured spectro-
photometrically at 450 nm using a SpectraMax® M2 microplate
reader.
ESI–MS of phospholipids extracted from vessels
The lipid content of uninjured, ligated and wire-injured arter-
ies was investigated using a modified version of the Bligh–Dyer
procedure [32] for lipid extraction from vessels. Briefly, LCA
and RCA were placed in methanol containing 100 μg/ml of
butylated hydroxytoluene, vortexed and sonicated for 15 min.
An equal volume of chloroform was then added, vortexed and
left overnight at 4 ◦C. An aqueous layer of 0.88% (w/v) KCl was
added to the mixture, vortexed and incubated at 4 ◦C for 20 min.
The layers were separated by centrifugation (13800 g for 1 min)
and the chloroform phase removed and dried under a steady flow
of oxygen-free nitrogen gas. Dried lipid extracts were reconsti-
tuted in 20% (v/v) chloroform in methanol and then diluted in
methanol. Samples were run in either positive- or negative-ion
mode by direct infusion on a QTRAP® 5500 mass spectrometer
(AB SCIEX). For analysis using positive-ionmode, samples were
diluted in 1% (v/v) aqueous formic acid in methanol, giving a
final dilution of the lipid extracts of one in 500 for LCA and one
in 250 for RCA. Spectra, in the range of m/z 400–1000, were
acquired for 2 min. Precursor ion scanning was performed for
m/z 184.1 which is selective for PCs (phosphatidylcholines) and
a neutral-ion loss scan of 141.1 Da for PEs (phosphatidylethan-
olamines). For analysis using negative-ion mode, samples were
diluted in 10% (v/v) 5 mM ammonium acetate in methanol, giv-
ing a final dilution of the lipid extracts of one in 50 for LCA
and one in 25 for RCA. Spectra, in the range of m/z 400–1000,
were acquired for 4 min. Neutral loss scan of 87.0 Da was per-
formed for PSs (phosphatidylserines). Samples were analysed by
looking for consistent differences observed between spectra from
different sample groups.
Preparation of chlorinated lipids
Native phospholipid [SOPC (1-stearoyl-2-oleoyl-sn-glycero-3-
phosphocholine)] and the oxidized lipids, PGPC and POVPC,
were purchased from Avanti Polar Lipids. Formation of chloro-
hydrins was assessed by the loss of the native phospholipid
and the addition of m/z 52 or 54 (differences being due to
the pattern of the chloride isotope, either 35Cl or 37Cl) to the
native phospholipid which was seen in its sodiated form (an
additional 22 m/z to the value compared with the protonated
form).
The α-chloro fatty aldehyde, 2-ClHDA, was synthesized
and provided by Professor Andrew R. Pitt (Aston University,
Birmingham, U.K.) following an adapted method previously de-
scribed [33]. Briefly, hexadecanol was oxidized to hexadecanal
using pyridinium chlorochromate in oxygen-free CH2Cl2, fol-
lowed by reaction with methanol and catalytic p-toluenesulfonic
acid to form the dimethyl acetal. The dimethyl acetal was then
α-chlorinated utilizing MnO2–trimethylchlorosilane. 2-ClHDA
was finally produced by refluxing the chloroacetal in 1:1 tri-
fluoroacetic acid:dichloromethane and purified by flash chroma-
tography using silica elution with 7:3 hexane:dichloromethane to
give solid 2-ClHDA (17% overall yield).
VSMC proliferation, viability and migration
Ideally, the in vitro effects of chlorinated and oxidized lipids
would have been tested in mouse VSMCs. However, in order
to provide a sufficient quantity of VSMCs for all assays, rab-
bit aortic SMCs (smooth muscle cells) were utilized and grown
from explants. Although derived from a different species, this
allowed us to test several oxidized and chlorinated lipids, several
incubation times and a range of concentrations, which would not
have been possible using mouse cells. Use of primary cells from
explants also avoided the use of immortalized cell lines or use
of cells at a high passage where features associated with VS-
MCs may have been lost. Briefly, aortae from male New Zealand
white rabbits (2.5–3.5 kg body weight) were excized and cleaned
of any connective tissue and fat. The outer and inner surface of
the vessel was scraped, removing the adventitia and endothe-
lium respectively. VSMCs were cultured in in 1:1 Waymouth’s
MB 752/1 and Ham’s F12 with GlutaMAX supplemented with
1% (v/v) penicillin–streptomycin solution and 10% (v/v) FCS
(fetal calf serum) and used between passages 3 and 8. Cells were
identified as VSMCs by positive immunofluorescent staining for
αSMA (result not shown). All oxidized or chlorinated lipids were
resuspended in serum-free VSMC medium at a concentration of
1× 10−2 M by vortexing and sonicating before diluting to the re-
quired concentration for cell treatment. Under these conditions,
the lipids form multilamellar vesicles rather than micelles or
liposomes.
The effect of modified lipids on cell proliferation was meas-
ured using a BrdU (bromodeoxyuridine) assay kit (Calbiochem).
Cells were seeded in 96-well plates at a density of 10000 cells
per well and quiesced in 0.1% (v/v) FCS-containing medium for
24 h. Cells were incubated with the chlorinated or oxidized lip-
ids (1–100 μM) for either 2 h in 0.1% FCS-containing medium
for acute experiments or, in the case of chronic exposure, for
24 h in the presence of 10% FCS. VSMCs were then stimulated
with 10% FCS-containing medium and addition of BrdU 24 h
prior to terminating the experiment. The assay was performed
as per the manufacturer’s instructions and proliferation was de-
tected using a spectrophotometric measurement of absorbance
at dual wavelengths of 450 and 540 nm using a SpectraMax M2
microplate reader.
Bioluminescent detection of cellular ATP using a ViaLightTM
Plus kit (Lonza) was employed to determine cell viability after
either 2 or 6 h in 0.1% FCS-containing medium or 24 h exposure
to the modified lipids in the presence of FCS. This assay enables
a comparison to be made between cells incubated under control
conditions with those incubated with lipids. A reduction in total
cellular ATP is indicative of a degree of cell apoptosis or necrosis
though it cannot distinguish between the two. Cells were prepared
as for the proliferation assay then lysis buffer was added to re-
lease cellular ATP. Following this, ATP Monitoring Reagent Plus
containing luciferase was added to the lysed cells to catalyse the
conversion of ATP and luciferin into emitted light. Luminescence
was measured using a POLARstar OPTIMA microplate reader
(BMG Labtech).
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Cell migration was measured using a CHEMICON® QCM
chemotaxis cell migration assay containing an 8 μm pore mem-
brane (Millipore). Cells were quiesced in 0.1% FCS-containing
medium for 24 h prior to stimulation. For pre-treatment exper-
iments, cells were incubated for 2 h with either the chlorinated
or oxidized lipids then harvested and added at 30000 cells/well
to the top chamber in serum-free medium. 10% FCS-containing
medium was utilized as the chemotactic agent in the lower cham-
ber. After 24 h, the remaining cells and media present in the
upper chamber were aspirated and non-migrated cells were re-
moved from the interior side of the insert. The membrane was
then stained, placed in the extraction buffer and the absorbance
measured at 560 nm using a SpectraMax M2 microplate reader.
For chronic experiments, the lipid was present in the top chamber
for the full 24-h stimulation period.
Statistical analysis
All results are expressed as mean+−S.E.M. Data were analysed
with GraphPad Prism 5.0 software using either a one-way AN-
OVA followed by a Dunnett’s or two-way ANOVA followed by
Bonferroni’s post-hoc test as appropriate. In all cases, P< 0.05
was considered statistically significant.
RESULTS
Extent of neointima formation in C57BL/6 and
ApoE−/− mice
Ligation of the LCA without wire injury resulted in formation
of measurable neointima compared with the contralateral, un-
injured RCA in both C57BL/6 and ApoE−/− mice (Figure 1A).
There was significantly more neointima, measured as the intima-
to-media ratio, present in injured ApoE−/− LCA compared with
both injured C57BL/6 vessels and ligated ApoE−/− vessels (Fig-
ure 1B). Measurement of the external elastic lamina length re-
vealed no difference in vessel circumference between groups and
microscopic examination of ApoE−/− aortae revealed no ath-
erosclerotic plaques (Figure 1A). However, ApoE−/− mice did
display a generalized inflammation characterized by significantly
increased plasmaMPO comparedwith C57BL/6mice in both lig-
ated and injured groups (Figure 1C) and a significantly increased
spleen weight relative to total body weight (result not shown).
Immunohistochemical analysis of neointima at 14 days revealed
no difference in the presence of VSMCs (αSMA; Figure 2A) or
proliferating cells (Ki67; Figure 2B). Minimal staining for act-
ive caspase 3, a marker of apoptosis, was found in all groups
(Figure 2C).
Presence of modified lipids in the arterial wall after
acute vascular injury
In the uninjured RCA, neither strain showed any positive staining
for oxLDL using the E06 antibody (Figure 3). In injured vessels,
ApoE−/− mice had a greater abundance of oxLDL present com-
pared with C57BL/6 mice where expression was lower and more
variable (Figure 3). Using ESI–MS, the ratios of different phos-
pholipids in uninjured, ligated and injured arteries fromC57BL/6
and ApoE−/− mice were studied. Some differences in lipid profile
between C57BL/6 and ApoE−/− carotid arteries were noted, but
more importantly, the response to ligation and injury differed.
Significantly higher relative levels of lysophosphatidylcholines
were found in both ligated and injured ApoE−/− carotid arteries
compared with the uninjured RCA whereas no change in lyso-
phosphatidylcholines were seen in C57BL/6 mice after vascular
injury (Figure 4). Precursor ion scanning for m/z 184.1 displayed
small elevations in the relative levels of PCs, m/z 734.9 (C32:0)
in ligated and injured carotid arteries of C57BL/6 mice and m/z
810.9 (C38:4) in ligated carotid arteries (Figures 4A and 4C). In
ApoE−/− mice, m/z 734.9 (C32:0) was also relatively increased
in ligated arteries, as was m/z 758.9 (C34:2) and 786.9 (C36:2)
in both ligated and injured vessels compared with the uninjured
RCA (Figures 4B and 4D). In comparison, there was a reduction
in the relative levels of m/z 782.9 (C36:4) and 810.9 (C38:4)
in injured ApoE−/− carotid arteries. No detectable changes were
observed in chain-shortened PCs. PEs and PSs were present at
considerably lower concentrations than PCs and there were no
significant changes across the groups in either strain of mice
(result not shown).
Effect of modified lipids on VSMC remodelling
processes
As we found changes in lysophosphatidylcholines and other PCs
in the injured vessel wall and since raised plasmaMPOmay form
modified lipids which could contribute to the greater neointima
formation in ApoE−/− mice, we assessed the effect of selected
chlorinated and oxidized lipids on VSMC remodelling processes.
Following acute exposure (2 h in 0.1% FCS-containing medium)
neither the phospholipid chlorohydrin, SOPC ClOH, nor the α-
chloro fatty aldehyde, 2-ClHDA, had any effect on VSMC pro-
liferation, viability or migration, even at concentrations as high
as 100 μM (Figure 5). In contrast, the oxidized lipids POVPC or
PGPC caused a significant reduction in VSMC proliferation and
viability at concentrations of 25 μM (PGPC) or 50 μM (POVPC)
and above. At lower, non-toxic concentrations neither oxidized
lipid affected VSMC migration (Figure 6). No morphological
changes were observed following either chlorinated lipid treat-
ment (Figure 5E); however, substantial cell death was evident
after incubation with 50 μM of either oxidized phospholipid
(Figure 6E). A longer incubation (6 h in 0.1% FCS-containing
medium) with SOPC ClOH caused a concentration-dependent
reduction in VSMC viability at 100 μM, whereas 2-ClHDA had
no effect (result not shown). As expected, 6 h incubation with
POVPC caused a dramatic reduction in VSMC viability (result
not shown).
Chronic incubation (24 h in 10% FCS-containing medium)
with SOPC ClOH or 2-ClHDA had no effect on VSMC prolif-
eration, viability or migration (result not shown). Paradoxically,
the decline in proliferation and viability seen after 2 h treatment
with POVPC was reversed with chronic incubation (Figures 7A–
7C) whereas PGPC significantly increased VSMC proliferation
and viability (Figures 7B–7D). However, both POVPC and PGPC
caused a marked reduction in migration at the highest concen-
tration studied (Figures 7F and 7G). No significant changes in
morphology were observed with either treatment (Figure 7E).
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Figure 1 Effect of vascular injury on the intima-to-media ratio and plasma MPO levels in C57BL/6 and ApoE−/− mice
(A) Representative histological sections of RCA and LCA from ligated and injured C57BL/6 and ApoE−/− mice using
haematoxylin and eosin staining. Scale bar for LCA and RCA = 100 μm, magnification = 10×. Scale for aorta = 250 μm,
magnification = 4×. (B) Neointimal growth in LCA after vascular injury was assessed as the intima-to-media ratio.
‡‡P< 0.01 compared with C57BL/6 injured, ††P< 0.01 compared with ApoE−/− ligated. Each bar represents the
mean +− S.E.M. of three or four animals. (C) The MPO content of mouse plasma was measured using a mouse MPO
ELISA kit. ∗∗∗P< 0.001 compared with C57BL/6 ligated, ‡‡‡P< 0.001 compared with C57BL/6 injured. Each bar repres-
ents the mean +− S.E.M. of six animals.
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Figure 2 Effect of vascular injury on smooth muscle, proliferative and apoptotic markers in C57BL/6 and ApoE−/− mice
Representative histological sections of injured LCA of C57BL/6 and ApoE−/− mice which were stained with (A) anti-αSMA,
(B) anti-Ki67 and (C) anti-active caspase 3 then counterstained with haematoxylin. Positive immunoreactivity for αSMA,
Ki67 or active caspase 3 was measured as a percentage of positive DAB staining divided by the neointimal area. Scale
bar = 100 μm, magnification = 10×. Each bar represents mean +− S.E.M. of three animals.
DISCUSSION
In the present study, we characterize for the first time the phos-
pholipid content of the arterial wall of C57BL/6 and ApoE−/−
mice after wire injury. Increased neointima formation was ob-
served in injured arteries in ApoE−/− mice, as well as elevated
plasmaMPO levels, increased oxLDL and an altered lipid profile
in the arterial wall in comparison with C57BL/6 mice and also
in comparison with the uninjured contralateral carotid artery.
In addition, the present study is the first to investigate the ef-
fects of chlorinated lipids on VSMC remodelling processes and
highlight the divergent effects of chlorinated and oxidized lipid
species. Chlorinated lipids had no effect on VSMC proliferation,
viability or migration, whereas oxidized phospholipids caused a
concentration-dependent reduction in all of these VSMC remod-
elling processes, which was reversed in the presence of FCS.
In the present study, neointima formation was dramatically
increased in injured ApoE−/− arteries compared with carotid
ligation without injury, whereas no significant differences were
observed in C57BL/6 mice. Increased neointima formation has
previously been observed following both wire and balloon injur-
ies in ApoE−/− mice [7,34,35] suggesting there is an increased
susceptibility for neointima formation in atherosclerotic or hyper-
lipidaemic mice. Elevated plasma MPO content could contribute
to the enhanced inflammatory state of these mice and result in an
increase in the production of reactive oxidants. Indeed, increased
oxLDL was detected in the neointima of ApoE−/− mice, which
may well, have occurred through the heightened inflammation
and/or MPO in the vessel wall after injury. Incubation of MPO
and its product, HOCl, in a temporarily isolated carotid artery
induced intimal and medial apoptosis which was followed by a
proliferative response and neointima hyperplasia in a rat model
[36]. In the present study, only the plasma MPO was measured
and therefore the level of MPO in the neointima is unknown.
However, greater infiltration of inflammatory cells at the site of
injury in ApoE−/− mice is likely to enhance the secretion ofMPO
in the developing neointima.
MPO is a known route for producing both chlorinated and ox-
idized lipid species in vivo. Intact phospholipid chlorohydrins
have yet to be observed in diseased vessels in vivo whereas
lysophosphatidylcholine–chlorohydrins have been detected in
human atherosclerotic vessels with a 60-fold increase in plaques
compared with healthy tissue [20]. We observed a marked el-
evation in the relative levels of lysolipids at m/z 496.7 (lyso-
palmitoyl PC) and 524.7 (lyso-stearoyl PC) in ligated and in-
jured ApoE−/− carotid arteries in comparison with the uninjured
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Figure 3 Detection of oxLDL in the carotid arteries of C57BL/6 and ApoE−/− mice
Representative histological sections of RCA and LCA of C57BL/6 (top) and ApoE−/− (bottom) mice which were stained
with E06 to detect oxLDL. Scale bar = 100 μm, magnification = 20× (left) or 10× (right).
vessels and C57BL/6 mice. Lysophosphatidylcholine has pre-
viously been found to induce apoptosis in VSMCs and promote
recruitment of monocytes [37,38], which could lead to an exacer-
bated inflammatory response at the site of injury. The precursor
ion scan form/z 184.1 displayed an increase in relative abundance
of unsaturated PCs such as m/z 758.9 (C34:2) and 786.9 (C36:2)
in ligated and injured LCA of ApoE−/− mice and a reduction in
m/z 782.9 (C36:4) and 810.9 (C38:4). This suggests there is an
increase in di-unsaturated species in ApoE−/− mice following
vascular injury but a reduction in arachidonate-containing PCs in
the injured arteries. These unsaturated PCs could then undergo
modification by MPO leading to a further increase in modified
lipids present at the site of injury. However, chain-shortened PCs
were not detected, which could be due to low concentrations
compared with their native phospholipids within these samples
or they may be metabolized or detoxified in vivo [39]. The high
levels of plasma MPO in ApoE−/− mice suggests the concept of
increased levels of HOCl and therefore of chlorinated lipids in
the vessels, although without a more extensive investigation by
LC–MS/MS and GC–MS and quantification of MPO within the
vessel itself is not possible to confirm this.
The levels of modified lipids found in pathophysiological con-
ditions have previously proved hard to quantify, owing to the
limited availability of suitable controls and the large number of
different structures present. A limitation of the present study is
the lack of internal or external standards in the ESI–MS analysis.
In the present study, the sizes and weights of the arteries varied,
thus the lipid concentrations could not be accurately calculated.
However, the amount of lipid present is likely to vary within the
artery, therefore, although standards may indicate the absolute
concentration, all lipids should fluctuate depending on the total
lipid content extracted. It should also be noted that ESI–MS is not
a quantitative technique in itself, due to the different ionization
efficiencies of lipid classes, therefore PC levels cannot be directly
compared with PEs or PSs. However, all these differences should
fluctuate concurrently between samples, thus it is valid to look for
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Figure 4 Effect of vascular injury on modified lipids present in the neointima and arterial wall of C57BL/6 and ApoE−/−
mice
(A) Precursor ion scanning for m/z 184.1 by positive-ionization ESI–MS identified the distribution of PCs in uninjured RCA,
ligated and injured LCA of C57BL/6 mice. Spectra shown are representative. The signal at m/z 564.0 was not identified
as a phospholipid species and is thought to be a contaminant from the HPLC system. (B) Precursor ion scanning for m/z
184.1 by positive-ionization ESI–MS identified the distribution of PCs in uninjured RCA, ligated and injured LCA of ApoE−/−
mice. Spectra shown are representative. (C) Relative intensities of detected PCs as a percentage of the largest peak in
C57BL/6 mice. ∗P< 0.05, ∗∗P< 0.01 and ∗∗∗P< 0.001 compared with uninjured. Each bar represents the mean +− S.E.M.
of three animals. (D) Relative intensities of detected PCs as a percentage of the largest peak in ApoE−/− mice. ∗P< 0.05,
∗∗P< 0.01 and ∗∗∗P< 0.001 compared with uninjured. Each bar represents the mean +− S.E.M. of three animals.
changes in relative intensities and patterns between samples. In
areas of inflammation, such as rheumatoid arthritis, the presence
of OCl−, the anion present in HOCl, has been found to reach
concentrations of up to 300 μM, due to the presence of neutro-
phils releasing MPO [40]. Levels of oxidized phospholipids have
also been found within the micromolar range in atherosclerotic
plaques in both human and animal tissue [41–43].
Within this concentration range, chlorinated lipids were found
to have little to no effect on VSMCs. The majority of work pub-
lished previously has observed toxicity with incubation of chloro-
hydrins thought to be caused by disruption of the membrane due
to their high polarity [17]. However, necrotic cell death has also
been reported in endothelial cells and an increase in caspase 3
levels suggesting apoptosis in myeloid cells [18,44]. The lack
of cytotoxicity described in the present study may be due to the
different cell type used, as VSMCs could be more resistant to the
effects of chlorohydrins than other cell types, or potential species
differences. In contrast with chlorohydrins, very little is known
about the actions of α-chloro fatty aldehydes as the few studies
conducted focused primarily on endothelial cells and nitric oxide
biosynthesis [45,46]. 2-ClHDA was thought to be an exciting
prospect with its identification in atherosclerotic lesions in vivo;
however, no effects were observed on the vascular remodelling
processes examined in the present study.
In stark contrast, oxidized phospholipids caused a dramatic
concentration-dependent reduction in VSMC proliferation and
viability after 2 h of incubation. These lipids have been found to
induce apoptotic signalling pathways by the activation of sphin-
gomyelinase and, in particular, the acid form of the enzymewhich
is known to be involved in the earlier stages of apoptosis res-
ulting in phosphorylation of mitogen activated protein kinase
(MAPK) and caspase 3 signalling [47,48]. A biphasic response
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Figure 5 Effect of acute treatment of chlorinated lipids on VSMC remodelling processes
VSMCs were incubated with 1–100 μM of SOPC ClOH or 2-ClHDA for 2 h prior to stimulation with 10 % FCS-containing
medium. (A and B) VSMC proliferation was assessed by incorporation of BrdU. (C and D) Cell viability was measured by
detection of cellular ATP. (E) Representative images of VSMCs treated with chlorinated lipids to visualize morphological
changes. (F and G) Cell migration was measured using a chemotaxis assay. Each bar represents the mean +− S.E.M. of six
animals for experiments performed in triplicate.
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Figure 6 Effect of acute treatment of oxidized phospholipids on VSMC remodelling processes
VSMCs were incubated with 1–100 μM of POVPC or PGPC for 2 h prior to stimulation with 10 % FCS-containing medium.
(A and B) VSMC proliferation was assessed by incorporation of BrdU. (C and D) Cell viability was measured by detection of
cellular ATP. (E) Representative images of VSMCs treated with oxidized phospholipids to visualize morphological changes.
(F and G) Cell migration was measured using a chemotaxis assay. ∗P< 0.05, ∗∗P< 0.01 and ∗∗∗P< 0.001 compared with
10 % FCS control. Each bar represents the mean +− S.E.M. of six animals for experiments performed in triplicate.
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Figure 7 Effect of chronic incubation of oxidized phospholipids on VSMC remodelling processes
(A and B) VSMC proliferation was assessed by incorporation of BrdU. (C and D) Cell viability was measured by detection of
cellular ATP. (E) Representative images of VSMCs treated with oxidized phospholipids to visualize morphological changes.
(F and G) Cell migration was measured using a chemotaxis assay. ∗P< 0.05 and ∗∗∗P< 0.001 compared with 10 % FCS
control. Each bar represents the mean +− S.E.M. of six animals for experiments performed in triplicate.
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of oxidized phospholipids has been reported previously with
proliferation occurring at low concentration and apoptosis pre-
dominating at high concentrations [27,29]. In the present study,
chronic incubation of oxidized phospholipids in the presence
of FCS abolished cell death and induced an increase in pro-
liferation and viability. This would suggest that the presence of
serum phospholipases causes a breakdown of oxidized phosphol-
ipids into a product with anti-apoptotic effects. This is in partial
agreement with a previous study; however, the anti-proliferative
nature of the lipids was still seen with the oxidized phosphol-
ipid treatment in the presence of FCS [28]. PGPC rather than
POVPC had the greater effect in all our experiments, despite
the fact that the latter has been suggested to be the more potent
of the two truncated oxidation products of PAPC [28,47]. How-
ever, recently PGPC has been reported to have a higher toxicity in
cultured macrophages due to more efficient membrane blebbing
in apoptotic cells [49].
Previous studies have found apoptosis to peak at about 24 h
after vascular injury whereas proliferation occurs later in the
process, at around 4 days after injury [7,36]. This correlates with
the oxidized phospholipid data described in the present study,
where VSMC death was induced after a short incubation time
of only 2 h. Modified lipids could also be involved in the latter
proliferative stages of vascular injury leading to the formation of
neointima; however, this would be difficult to measure in vitro.
Longer incubations would require medium containing growth
supplements such as FCS which would lead to the breakdown
of these lipids as shown in the present study and in a study by
Fruhwirth et al. [28].
In conclusion, we have detected alterations in severalmodified
lipids in ligated and wire-injured carotid arteries from ApoE−/−
mice compared with uninjured vessels and C57BL/6 controls.
These differences are likely to be a consequence of heightened
inflammatory state in the plasma of hyperlipidaemic ApoE−/−
mice coupled with inflammatory cell infiltration following wire
injury. Our in vitro data suggest that chlorinated lipids are un-
likely to be involved in vascular smooth muscle remodelling
processes which lead to neointima formation. However, incuba-
tion of oxidized lipids in the presence of FCS led to increased
proliferation and accumulation of these species in the artery
wall following injury and so they may be involved in propagat-
ing neointima formation. This hypothesis requires to be tested
in vivo.
CLINICAL PERSPECTIVES
 Abnormal VSMC proliferation and migration contribute to
restenosis in patients following revascularization techniques
such as balloon angioplasty or stent implantation. MPO and
modified lipids have been found to be vital mediators in the
propagation of the inflammatory response and plaque form-
ation, suggesting they could be viable targets in preventing
restenosis.
 The present study shows the altered phospholipid expres-
sion within the injured arterial wall of hyperlipidaemic
mice and elevated MPO levels. In addition, there were di-
vergent effects of modified lipids on VSMC remodelling
processes.
 These findings suggest that changes in unsaturated phosphol-
ipids could be involved in initiating and maintaining VSMC
remodelling processes which are critical in restenosis in pa-
tients and therefore could be targeted for future therapies.
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